BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: c-Met receptor tyrosine kinase (c-MET; MET; HGFR; c-Met proto-oncogene)

June 18, 2015 7:00 AM UTC

Cell culture, mouse and patient studies suggest c-MET inhibitors could help treat a subset of melanomas. Copy number analysis in tumor samples from 1,022 patients with melanocytic tumors lacking known...